# Randomized Trial Comparing Sitagliptin to Placebo in Closed Loop

> **NCT02328040** · PHASE1 · COMPLETED · sponsor: **Albert Einstein College of Medicine** · enrollment: 17 (actual)

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** Placebo and Insulin monotherapy via CL
- **DRUG:** Sitagliptin and insulin/novolog via CL

## Key facts

- **NCT ID:** NCT02328040
- **Lead sponsor:** Albert Einstein College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2016-01
- **Final completion:** 2016-01
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2018-08-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02328040

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02328040, "Randomized Trial Comparing Sitagliptin to Placebo in Closed Loop". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02328040. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*